GSK3β Inhibitor II is a potent inhibitor of glycogen synthase kinase-3β (GSK3β; IC50 = 390 nM) that does not inhibit GSK-3α. ChemeGen 作为优秀的抑制剂、激动剂及新型生命科学试剂的供应商,致力于为广大科研、商业实验室的科学研究者提供高品质的产品与技术服务,不断促进生命科学领域的新技术发展...
GSK3β inhibitor II 纯度:99.32% 产品编号T21956Cas号478482-75-6 GSK3β inhibitor II 是 GSK3β 的抑制剂。GSK3β inhibitor II 可用于研究阿尔茨海默病 (AD)。 规格价格库存数量 1 mg ¥ 113 现货 5 mg ¥ 268 现货 10 mg ¥ 461
GSK-3β inhibitor II Pyridine, 4-[5-[[(3-iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]- [ACD/Index Name] Unverified 2-[(3-iodophenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole 2-Thio(3-iodobenzyl)-5-(1-pyridyl)-[1,3,4]-oxadiazole ...
IC50: 390 nM for GSK-3β GSK-3β Inhibitor II is a GSK-3β inhibitor. Glycogen Synthase Kinase-3 (GSK-3), a protein-serine kinase, is implicated in the hormonal control of various regulatory proteins. A number of substrates have been identified, which implicates GSK-3 in the regulation...
CAS:478482-75-6分子式:C₁₄H₁₀IN₃OS分子量:395.20 化合物信息 安全信息 英文名称: GSK-3β Inhibitor II CAS No.: 478482-75-6 分子式: C₁₄H₁₀IN₃OS 分子量: 395.20 技术问答 现在暂时无人提问问题 Tags:478482-75-6,GSK-3β Inhibitor II,cas号:478482-75-6,cas:478482...
相关信息:产品目录(40582) 用户评价 英文名称:GSK-3β Inhibitor II 1PC x 5MG 欣博盛生物科技有限公司 联系电话:4006-800-892 电子邮件:info@neobioscience.com CB指数:58 网址:www.nbs-bio.com 相关信息:产品目录(6207) 用户评价 英文名称:GSK-3β Inhibitor II 1PC x 5MG Tag...
WE-148. TIDALS: Protocol for a randomized, placebo-controlled, double-blind phase II trial of the GSK3-inhibitor Tideglusib in amyotrophic lateral sclerosisdoi:10.1016/j.clinph.2022.07.192Annemarie HübersElsevier B.V.Clinical Neurophysiology...
GSK-3β Inhibitor II 1PC x 5MG| 基本信息 更多信息 中文名称: 中文同义词: 英文名称: GSK-3β Inhibitor II 1PC x 5MG 英文同义词: GSK-3β Inhibitor II 1PC x 5MG CAS号: 分子式: 分子量: 0 EINECS号: 信息错误报告 您的Email: 按国家浏览GSK-3β Inhibitor II 1PC x 5MG国外供应...
del Ser T, Lovestone S, Boada-Rovira M, Dubois B, Hüll M, Rinne J et al (2013) A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer’s disease (ARGO trial). Alzheimers Dement 9(4):P689–P690...
Background 9-ING-41 is a first-in-class, intravenously (IV) administered, small molecule potent selective GSK-3尾 inhibitor with significant pre-clinical antitumor activity in a broad spectrum of malignancies, both as a single agent and in combination with cytotoxic agents. GSK-3尾 is a ...